Santhera Pharmaceuticals Holding AG (LON:0QN1)

LON:0QN1 Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	178	84	68	45	45	98
Market Cap Growth	-1.70%	24.57%	49.48%	1.30%	-54.55%	72.36%
Enterprise Value	187	121	93	74	80	138
Last Close Price	14.09	9.15	12.58	10.29	22.72	89.66
PE Ratio	3.22	1.65	-	-	-	-
PS Ratio	0.83	0.87	10.08	-35.00	3.59	1.67
PB Ratio	1.96	1.51	-1.72	42.04	-8.49	5.93
P/FCF Ratio	1.99	1.91	-	-	-	50.46
P/OCF Ratio	1.99	1.91	-	-	-	48.56
EV/Sales Ratio	1.87	1.26	13.82	-	6.41	2.35
EV/EBITDA Ratio	3.68	2.42	-	-	-	-
EV/EBIT Ratio	3.95	2.54	-	-	-	-
EV/FCF Ratio	4.50	2.76	-	-	-	71.03
Debt / Equity Ratio	0.55	0.36	-1.02	32.36	-11.20	2.82
Debt / EBITDA Ratio	0.46	0.40	-	-	-	-
Debt / FCF Ratio	0.56	0.46	-	-	-	24.03
Asset Turnover	1.33	1.19	0.10	-	0.15	0.67
Inventory Turnover	-	3.37	13.40	8.29	2.84	0.68
Quick Ratio	0.51	0.73	0.05	0.71	0.58	1.68
Current Ratio	0.63	0.78	0.06	0.75	0.61	2.06
Return on Equity (ROE)	2374.13%	673.95%	-	-	-908.60%	-77.32%
Return on Assets (ROA)	39.20%	36.89%	-36.95%	-39.55%	-32.56%	-5.79%
Return on Capital (ROIC)	91.78%	77.76%	-126.97%	-65.17%	-45.43%	-7.98%
Return on Capital Employed (ROCE)	97.33%	78.33%	-	-	-	-
Earnings Yield	31.07%	60.65%	-94.37%	-99.46%	-125.46%	-15.06%
FCF Yield	23.32%	52.24%	-39.69%	-66.93%	-80.73%	1.98%
Buyback Yield / Dilution	-24.61%	-79.29%	-78.31%	-156.61%	-21.15%	-59.49%
Total Shareholder Return	-24.61%	-79.29%	-78.31%	-156.61%	-21.15%	-59.49%

Source: S&P Capital IQ. Standard template. Financial Sources.